Font Size:
a
A
A
Keyword [Programmed death-ligand]
Result: 141 - 155 | Page: 8 of 8
141.
Long Intergenic Non-Coding RNA LINC01088 Facilitates Malignant Phenotypes And Immune Escape Of Colorectal Cancer
142.
Detection Of DNA Damage And Analysis Of PD-L1 Expression In Ovarian Cancer By Modified DNA Damage Detection Technique
143.
Clinical Study On The Relationship Between The Expression Of Programmed Death Ligand-1 And Tumor Grade And Clinical Stage Of Upper Urothelial Carcinoma
144.
Features Of Patients With Advanced EGFR-mutated Non-small Cell Lung Cancer Benefiting From Immune Checkpoint Inhibitors
145.
Expression Of PD-1/PD-L1 In Different Histological Subtypes Of Nasopharyngeal Carcinoma And Its Clinical Significance
146.
The Interference And Related Mechanisms Of Low Density Granulocytes On T-SPOT.TB Results In Rheumatoid Arthritis
147.
PTPRD Affects The Expression Of PD-L1 In Human Hepatocellular Carcinoma By Down-regulating STAT3
148.
The Clinicopathological Significance Of PD-L1 Expression And Construction Of The B Cell Marker Gene Signature In Head And Neck Squamous Cell Carcinoma
149.
Expression And Significance Of EBER,PD-L1,CD4 And CD8 In Diffuse Large B-cell Lymphoma And Hodgkin Lymphoma
150.
Meta-Analysis Of The Relationship Between The Expression Of PD-L1 And The Pathological Characteristics And Prognosis Of Oral Squamous Cell Carcinoma
151.
The Mechanism Of GBP2 In Immune Infiltration And Regulation Of PD-L1 Expression In Clear Cell Renal Cell Carcinoma
152.
Correlation Between MSI Status,PD-L1 Expression And Regional Lymph Node Metastasis In Gastric Adenocarcinoma
153.
Effect And Mechanisms Of PD-1/PD-L1 Expression On Nasopharyngeal Carcinoma
154.
The Expression And Significance Of HP Infection And C-MET,PD-L1 In Gastric Cancer And Precancerous Lesions
155.
Application Of Multifunctional Peptides In SPD-L1 Sensitive Detection
<<First
<Prev
Next>
Last>>
Jump to